David C Fajgenbaum Selected Research

COVID-19

1/2022	Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling.
1/2022	Anti-type I interferon antibodies as a cause of severe COVID-19.
1/2021	Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.
1/2020	Teaching Old Drugs New Tricks: Statins for COVID-19?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David C Fajgenbaum Research Topics

Disease

28	Castleman Disease (Castleman's Disease) 02/2024 - 12/2015
21	Thrombocytopenia (Thrombopenia) 02/2024 - 02/2016
20	Edema (Dropsy) 02/2024 - 02/2016
18	Fever (Fevers) 02/2024 - 02/2016
15	Fibrosis (Cirrhosis) 02/2024 - 02/2016
13	Cytokine Release Syndrome 01/2024 - 05/2014
10	Inflammation (Inflammations) 01/2024 - 11/2018
9	Lymphadenopathy 02/2024 - 04/2016
8	Multi-centric Castleman's Disease 08/2022 - 05/2014
6	Cytopenia 04/2022 - 03/2017
5	Renal Insufficiency (Renal Failure) 01/2024 - 01/2017
5	Thrombocytosis (Thrombocythemia) 01/2024 - 03/2017
4	COVID-19 01/2022 - 01/2020
4	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 05/2017
3	Rare Diseases (Rare Disease) 10/2022 - 12/2015
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2022 - 01/2019
3	Anemia 01/2022 - 03/2017
3	Neoplasms (Cancer) 01/2022 - 01/2020
3	Ascites 11/2021 - 04/2016
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 04/2022 - 03/2017
2	Autoimmune Lymphoproliferative Syndrome 01/2022 - 01/2020
2	Hypoalbuminemia 01/2022 - 03/2017
1	Immunoglobulin G4-Related Disease 02/2024
1	Hyperplasia 04/2022
1	Primary Effusion Lymphoma 11/2021
1	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2021
1	POEMS Syndrome (Syndrome, POEMS) 11/2021
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Leukocytosis (Pleocytosis) 02/2020
1	Hypersensitivity (Allergy) 01/2020
1	Histiocytosis 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Disease Progression 01/2018
1	Proteinuria 03/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2017
1	Splenomegaly 04/2016
1	Hepatomegaly 04/2016
1	Acute Kidney Injury (Acute Renal Failure) 02/2016
1	Abdominal Pain (Pain, Abdominal) 02/2016
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 05/2014

Drug/Important Bio-Agent (IBA)

19	Reticulin (Reticular Fiber)IBA 02/2024 - 02/2016
15	Interleukin-6 (Interleukin 6)IBA 01/2024 - 05/2014
10	CytokinesIBA 10/2022 - 05/2014
7	C-Reactive ProteinIBA 01/2024 - 04/2016
5	siltuximabIBA 10/2022 - 01/2016
3	Sirolimus (Rapamycin)FDA Link 01/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2021
2	Immunoglobulin G (IgG)IBA 02/2024 - 01/2022
2	AntibodiesIBA 01/2022 - 01/2017
2	AutoantibodiesIBA 01/2021 - 05/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 04/2016
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 05/2017
1	Messenger RNA (mRNA)IBA 10/2022
1	COVID-19 VaccinesIBA 10/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Interferon Type IIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	InterleukinsIBA 09/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2021
1	CreatinineIBA 02/2020
1	AA amyloidosisIBA 02/2020
1	Interleukin-3 (Interleukin 3)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Thalidomide (Thalomid)FDA Link 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Rituximab (Mabthera)FDA Link 09/2018
1	ChemokinesIBA 01/2018
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 04/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016
1	Alkaline PhosphataseIBA 02/2016
1	NexusIBA 01/2016
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2016

Therapy/Procedure

10	Therapeutics 01/2023 - 05/2014
2	Drug Therapy (Chemotherapy) 11/2023 - 04/2016
2	Precision Medicine 01/2019 - 12/2015
1	Immunomodulation 01/2021